5/30
07:30 am
snse
Sensei Biotherapeutics to Participate in Jefferies Global Healthcare Conference
Medium
Report
Sensei Biotherapeutics to Participate in Jefferies Global Healthcare Conference
5/24
01:04 pm
snse
Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Medium
Report
Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
5/24
12:18 pm
snse
Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $5.00 price target on the stock.
Medium
Report
Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $5.00 price target on the stock.
5/23
05:20 pm
snse
Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-101 [Yahoo! Finance]
Low
Report
Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-101 [Yahoo! Finance]
5/23
05:10 pm
snse
Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-101
Medium
Report
Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-101
5/14
08:07 am
snse
Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) is now covered by analysts at Stephens. They set an "overweight" rating and a $5.00 price target on the stock.
Medium
Report
Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) is now covered by analysts at Stephens. They set an "overweight" rating and a $5.00 price target on the stock.
5/10
11:45 am
snse
EGLE Therapeutics Strengthens its Leadership Team with the Appointment of Pejvack Motlagh, MD, MSc, as Chief Medical Officer and its Board of Directors with Appointment of John Celebi, MBA, as Independent Board Member
Medium
Report
EGLE Therapeutics Strengthens its Leadership Team with the Appointment of Pejvack Motlagh, MD, MSc, as Chief Medical Officer and its Board of Directors with Appointment of John Celebi, MBA, as Independent Board Member
5/9
07:40 am
snse
Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
High
Report
Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
5/9
07:30 am
snse
Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
High
Report
Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
4/24
04:05 pm
snse
Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting
Low
Report
Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting
4/9
07:30 am
snse
Sensei Biotherapeutics to Participate in Canaccord Genuity’s Horizons in Oncology Virtual Conference
High
Report
Sensei Biotherapeutics to Participate in Canaccord Genuity’s Horizons in Oncology Virtual Conference
4/4
04:16 pm
snse
Sensei Biotherapeutics Announces Nature Communications Publication Describing Mechanism of Action of SNS-101 Selectively Targeting the Active Form of VISTA within the Tumor Microenvironment [Yahoo! Finance]
Medium
Report
Sensei Biotherapeutics Announces Nature Communications Publication Describing Mechanism of Action of SNS-101 Selectively Targeting the Active Form of VISTA within the Tumor Microenvironment [Yahoo! Finance]
4/4
04:05 pm
snse
Sensei Biotherapeutics Announces Nature Communications Publication Describing Mechanism of Action of SNS-101 Selectively Targeting the Active Form of VISTA within the Tumor Microenvironment
Low
Report
Sensei Biotherapeutics Announces Nature Communications Publication Describing Mechanism of Action of SNS-101 Selectively Targeting the Active Form of VISTA within the Tumor Microenvironment
3/22
07:30 am
snse
Sensei Biotherapeutics to Participate in the 3rd Annual VISTA Symposium
High
Report
Sensei Biotherapeutics to Participate in the 3rd Annual VISTA Symposium
3/6
07:38 am
snse
Sensei Biotherapeutics to Present New Preclinical Data at Upcoming Scientific Conferences [Yahoo! Finance]
Low
Report
Sensei Biotherapeutics to Present New Preclinical Data at Upcoming Scientific Conferences [Yahoo! Finance]
3/6
07:30 am
snse
Sensei Biotherapeutics to Present New Preclinical Data at Upcoming Scientific Conferences
Low
Report
Sensei Biotherapeutics to Present New Preclinical Data at Upcoming Scientific Conferences